News

Universal CDx designed to support patient selection for specific therapies in non-small cell lung cancer and multiple drug development programs.

Scientists develop computational metabolomic approach to measure metabolic diversity in different plant tissues.

New study suggests that a mammalian bone and muscle gene may be repurposed to fuel cognition in humans

Collaboration aims to speed up clinical interpretation of cancer genomics.

The financing will fuel the completion and launch of Genomenon’s initial product, Mastermind, a novel analytic and visualization tool for DNA variant interpretation.

Acquisition to develop an end-to-end solution for molecular and genetic testing.

Partnership aims to provide oncologists with comprehensive next generation sequencing of solid tumors for clinical decision support.

Collaboration aims to develop high-quality sequence data from the BioMe cohort.

Partnership aims to make advancements in NGS technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise.

The $50M project will study thousands of drug resistant tumors and draw on Watson’s computational and machine learning methods to help researchers understand how cancers become resistant to therapies.